Clinicians, engineers, operators, and counsel — a team built to carry bioadaptive medicine from first principles to first patients.
A MedTech executive with more than 28 years of global leadership across medical devices, drug–device combinations, biologics, and pharmaceuticals. Jeff has guided public and private companies through pivotal growth phases — raising capital, building ISO 13485/MDSAP-grade quality systems, and running multi-billion-dollar businesses across interventional pain, spine, and neuroscience. BS in Health Science; executive leadership training at Stanford.
A board-certified neurosurgeon and PhD biomedical engineer, Erich founded Wavegate to rebuild neuromodulation around the patient in front of it. Inventor or co-inventor on numerous U.S. and international patents spanning near-infrared reflectometry, stimulation optimization, and implantable sensing and telemetry, he architects the Ellipse™ platform from optical front end to adaptive control. MD/PhD, Tulane University; neurosurgical residency, University of Tennessee; FACS, FAANS.
Brian pairs two decades of device product development with hands-on AI. He co-founded AZAR Technologies, building patient-facing AI systems for spinal cord stimulation; held senior strategy and business-development roles at Cerapedics; and managed global launches at Medtronic across pain management and neuromodulation, including RF ablation and SCS platforms. MBA, University of Pittsburgh.
A finance leader with 30 years across public and private companies, Laura has served as fractional CFO to multiple early-stage bioscience and medical-device companies — specializing in equity and structured-debt capital raises and licensing transactions. She began her career at PricewaterhouseCoopers and Ernst & Young. BAcc, University of San Diego.
Charlotte provides cohesion across Wavegate's design, regulatory, and production teams — and has been part of Ellipse™ since its inception as a graduate research project. BSE in Biomedical Engineering, MS in Engineering & Technology Management, and MBA from Louisiana Tech University, where she is a doctoral candidate; Six Sigma Green Belt and Lean certified.
Paul serves as corporate secretary, investor liaison, and Outside General Counsel. With in-house, major-firm, and fractional-GC experience, he guides early- and growth-stage companies through formation, governance, IP strategy and licensing, and the transactions that turn strategy into partnerships. JD, University of Denver; BA with distinction, University of Colorado Boulder.
We work with clinicians, researchers, and partners who share our view of where neuromodulation is going.